featured
Efficacy of SGLT2 Inhibitors in Restoring Glucagon and Counterregulatory Hormone Response to Hypoglycemia in T1D
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes
Diabetes 2022 Mar 01;71(3)511-519, SC Boeder, JM Gregory, ER Giovannetti, JH PettusFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.